Metabolic evaluation of urinary lithiasis: what urologists should know and do

详细信息    查看全文

• 作者：Julien Letendre (1)
  Jonathan Cloutier (2)
  Luca Villa (2)
  Luc Valiquette (3)
  
  1. H么pital Maisonneuve-Rosemont ; Montreal ; QC ; Canada
  2. H么pital Tenon ; Paris ; France
  3. Centre Hospitalier de l鈥橴niversit茅 de Montr茅al ; Montr茅al ; QC ; Canada
  
• 关键词：Stones ; Urolithiasis ; Kidney Calculi/*metabolism ; Lithiasis/*metabolism ; Hypercalciuria
• 刊名：World Journal of Urology
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：33
• 期：2
• 页码：171-178
• 全文大小：217 KB
• 参考文献：1. Paterson R, Fernandez A, Razvi H, Sutton R (2010) Evaluation and medical management of the kidney stone patient. Can Urol Assoc J 4(6):375鈥?79 href="http://dx.doi.org/10.5489/cuaj.10166" target="_blank" title="It opens in new window">CrossRef
  2. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR, American Urological A (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316鈥?24. doi:10.1016/j.juro.2014.05.006 href="http://dx.doi.org/10.1016/j.juro.2014.05.006" target="_blank" title="It opens in new window">CrossRef
  3. T眉rk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C (2014) The updated EAU guidelines on urolithiasis. EAU Guidelines, edition presented at the 29th EAU annual congress, Stockholm
  4. Pearle MS, Roehrborn CG, Pak CY (1999) Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13(9):679鈥?85 href="http://dx.doi.org/10.1089/end.1999.13.679" target="_blank" title="It opens in new window">CrossRef
  5. Borghi L, Meschi T, Guerra A, Novarini A (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22(Suppl 6):S78鈥揝86 href="http://dx.doi.org/10.1097/00005344-199312050-00014" target="_blank" title="It opens in new window">CrossRef
  6. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158(6):2069鈥?073 href="http://dx.doi.org/10.1016/S0022-5347(01)68155-2" target="_blank" title="It opens in new window">CrossRef
  7. Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139(4):679鈥?84
  8. Ettinger B, Tang A, Citron JT, Livermore B, Williams T (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315(22):1386鈥?389. doi:10.1056/NEJM198611273152204 href="http://dx.doi.org/10.1056/NEJM198611273152204" target="_blank" title="It opens in new window">CrossRef
  9. Laerum E, Larsen S (1984) Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215(4):383鈥?89 href="http://dx.doi.org/10.1111/j.0954-6820.1984.tb05023.x" target="_blank" title="It opens in new window">CrossRef
  10. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150(6):1761鈥?764
  11. Hofbauer J, Hobarth K, Szabo N, Marberger M (1994) Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis鈥揳 prospective randomized study. Br J Urol 73(4):362鈥?65 href="http://dx.doi.org/10.1111/j.1464-410X.1994.tb07597.x" target="_blank" title="It opens in new window">CrossRef
  12. Scholz D, Schwille PO, Sigel A (1982) Double-blind study with thiazide in recurrent calcium lithiasis. J Urol 128(5):903鈥?07
  13. Pak CY, Sakhaee K, Fuller C (1986) Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int 30(3):422鈥?28 href="http://dx.doi.org/10.1038/ki.1986.201" target="_blank" title="It opens in new window">CrossRef
  14. Pak CY, Odvina CV, Pearle MS, Sakhaee K, Peterson RD, Poindexter JR, Brinkley LJ (2005) Effect of dietary modification on urinary stone risk factors. Kidney Int 68(5):2264鈥?273. doi:10.1111/j.1523-1755.2005.00685.x href="http://dx.doi.org/10.1111/j.1523-1755.2005.00685.x" target="_blank" title="It opens in new window">CrossRef
  15. Lotan Y, Pearle MS (2011) Cost-effectiveness of primary prevention strategies for nephrolithiasis. J Urol 186(2):550鈥?55. doi:10.1016/j.juro.2011.03.133 href="http://dx.doi.org/10.1016/j.juro.2011.03.133" target="_blank" title="It opens in new window">CrossRef
  16. Eisner BH, Sheth S, Dretler SP, Herrick B, Pais VM Jr (2012) Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers. Urology 80(4):776鈥?79. doi:10.1016/j.urology.2012.06.034 href="http://dx.doi.org/10.1016/j.urology.2012.06.034" target="_blank" title="It opens in new window">CrossRef
  17. Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America P (2012) Prevalence of kidney stones in the United States. Eur Urol 62(1):160鈥?65. doi:10.1016/j.eururo.2012.03.052 href="http://dx.doi.org/10.1016/j.eururo.2012.03.052" target="_blank" title="It opens in new window">CrossRef
  18. Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162(1):27鈥?0. doi:10.1097/00005392-199907000-00007 href="http://dx.doi.org/10.1097/00005392-199907000-00007" target="_blank" title="It opens in new window">CrossRef
  19. Worcester EM, Coe FL (2008) New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 28(2):120鈥?32. doi:10.1016/j.semnephrol.2008.01.005 href="http://dx.doi.org/10.1016/j.semnephrol.2008.01.005" target="_blank" title="It opens in new window">CrossRef
  20. Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14聽years of follow-up. J Am Soc Nephrol 15(12):3225鈥?232. doi:10.1097/01.ASN.0000146012.44570.20 href="http://dx.doi.org/10.1097/01.ASN.0000146012.44570.20" target="_blank" title="It opens in new window">CrossRef
  21. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155(3):839鈥?43 href="http://dx.doi.org/10.1016/S0022-5347(01)66321-3" target="_blank" title="It opens in new window">CrossRef
  22. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ (1996) Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 143(3):240鈥?47 href="http://dx.doi.org/10.1093/oxfordjournals.aje.a008734" target="_blank" title="It opens in new window">CrossRef
  23. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346(2):77鈥?4. doi:10.1056/NEJMoa010369 href="http://dx.doi.org/10.1056/NEJMoa010369" target="_blank" title="It opens in new window">CrossRef
  24. Smith-Bindman R, Aubin C, Bailitz J, Bengiamin RN, Camargo CA Jr, Corbo J, Dean AJ, Goldstein RB, Griffey RT, Jay GD, Kang TL, Kriesel DR, Ma OJ, Mallin M, Manson W, Melnikow J, Miglioretti DL, Miller SK, Mills LD, Miner JR, Moghadassi M, Noble VE, Press GM, Stoller ML, Valencia VE, Wang J, Wang RC, Cummings SR (2014) Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med 371(12):1100鈥?110. doi:10.1056/NEJMoa1404446 href="http://dx.doi.org/10.1056/NEJMoa1404446" target="_blank" title="It opens in new window">CrossRef
  25. McPhail EF, Gettman MT, Patterson DE, Rangel LJ, Krambeck AE (2012) Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. Urology 79(2):277鈥?81. doi:10.1016/j.urology.2011.07.1414 href="http://dx.doi.org/10.1016/j.urology.2011.07.1414" target="_blank" title="It opens in new window">CrossRef
  26. Gambaro G, Fabris A, Puliatta D, Lupo A (2006) Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res 34(2):102鈥?07. doi:10.1007/s00240-005-0019-z href="http://dx.doi.org/10.1007/s00240-005-0019-z" target="_blank" title="It opens in new window">CrossRef
  27. Norman RW, Bath SS, Robertson WG, Peacock M (1984) When should patients with symptomatic urinary stone disease be evaluated metabolically? J Urol 132(6):1137鈥?139
  28. Nayan M, Elkoushy MA, Andonian S (2012) Variations between two 24-h urine collections in patients presenting to a tertiary stone clinic. Can Urol Assoc J 6(1):30鈥?3. doi:10.5489/cuaj.11131
  29. Parks JH, Goldfisher E, Asplin JR, Coe FL (2002) A single 24-h urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 167(4):1607鈥?612 href="http://dx.doi.org/10.1016/S0022-5347(05)65163-4" target="_blank" title="It opens in new window">CrossRef
  30. Pak CY, Peterson R, Poindexter JR (2001) Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol 165(2):378鈥?81. doi:10.1097/00005392-200102000-00006 href="http://dx.doi.org/10.1097/00005392-200102000-00006" target="_blank" title="It opens in new window">CrossRef
  31. Yagisawa T, Chandhoke PS, Fan J (1999) Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 161(5):1449鈥?452 href="http://dx.doi.org/10.1016/S0022-5347(05)68922-7" target="_blank" title="It opens in new window">CrossRef
  32. Worcester EM, Coe FL (2010) Clinical practice. Calcium kidney stones. N Engl J Med 363(10):954鈥?63. doi:10.1056/NEJMcp1001011 href="http://dx.doi.org/10.1056/NEJMcp1001011" target="_blank" title="It opens in new window">CrossRef
  33. Daudon M, Lacour B, Jungers P (2005) High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 20(2):468鈥?69. doi:10.1093/ndt/gfh594 href="http://dx.doi.org/10.1093/ndt/gfh594" target="_blank" title="It opens in new window">CrossRef
  34. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY (2004) Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65(4):1422鈥?425. doi:10.1111/j.1523-1755.2004.00522.x href="http://dx.doi.org/10.1111/j.1523-1755.2004.00522.x" target="_blank" title="It opens in new window">CrossRef
  35. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65(2):386鈥?92. doi:10.1111/j.1523-1755.2004.00386.x href="http://dx.doi.org/10.1111/j.1523-1755.2004.00386.x" target="_blank" title="It opens in new window">CrossRef
  36. Hamm LL, Hering-Smith KS (2002) Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am 31(4):885鈥?93, viii
  37. Curhan GC, Willett WC, Speizer FE, Stampfer MJ (2001) Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59(6):2290鈥?298. doi:10.1046/j.1523-1755.2001.00746.x
  38. Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CY (2002) Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40(2):265鈥?74. doi:10.1053/ajkd.2002.34504 href="http://dx.doi.org/10.1053/ajkd.2002.34504" target="_blank" title="It opens in new window">CrossRef
  39. Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, Hruska K (1990) Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 71(1):138鈥?45. doi:10.1210/jcem-71-1-138 href="http://dx.doi.org/10.1210/jcem-71-1-138" target="_blank" title="It opens in new window">CrossRef
  40. Yu TF (1978) Nephrolithiasis in patients with gout. Postgrad Med 63(5):164鈥?70
  41. Pak CY, Adams-Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW (2004) Rapid communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 66(5):2032鈥?037. doi:10.1111/j.1523-1755.2004.00975.x href="http://dx.doi.org/10.1111/j.1523-1755.2004.00975.x" target="_blank" title="It opens in new window">CrossRef
  42. Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD (2002) Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 41(3):318鈥?22 href="http://dx.doi.org/10.1016/S0302-2838(02)00040-4" target="_blank" title="It opens in new window">CrossRef
  43. Pak CY (1991) Citrate and renal calculi: new insights and future directions. Am J Kidney Dis 17(4):420鈥?25 href="http://dx.doi.org/10.1016/S0272-6386(12)80635-4" target="_blank" title="It opens in new window">CrossRef
  44. Moe OW, Abate N, Sakhaee K (2002) Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am 31(4):895鈥?14 href="http://dx.doi.org/10.1016/S0889-8529(02)00032-4" target="_blank" title="It opens in new window">CrossRef
  45. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE (2004) Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 66(2):777鈥?85. doi:10.1111/j.1523-1755.2004.00803.x href="http://dx.doi.org/10.1111/j.1523-1755.2004.00803.x" target="_blank" title="It opens in new window">CrossRef
  46. Pak CY, Poindexter JR, Adams-Huet B, Pearle MS (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115(1):26鈥?2 href="http://dx.doi.org/10.1016/S0002-9343(03)00201-8" target="_blank" title="It opens in new window">CrossRef
  47. Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MA (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 151(3):571鈥?74
  48. Daudon M, Reveillaud RJ (1984) Whewellite and weddellite: toward a different etiopathogenesis. The significance of morphological typing of calculi. Nephrologie 5(5):195鈥?01
  49. Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL (2003) Urine calcium and volume predict coverage of renal papilla by Randall鈥檚 plaque. Kidney Int 64(6):2150鈥?154. doi:10.1046/j.1523-1755.2003.00316.x href="http://dx.doi.org/10.1046/j.1523-1755.2003.00316.x" target="_blank" title="It opens in new window">CrossRef
  50. Moreira DM, Friedlander JI, Hartman C, Elsamra SE, Smith AD, Okeke Z (2013) Using 24-hour urinalysis to predict stone type. J Urol 190(6):2106鈥?111. doi:10.1016/j.juro.2013.05.115 href="http://dx.doi.org/10.1016/j.juro.2013.05.115" target="_blank" title="It opens in new window">CrossRef
  51. Torricelli FC, De S, Liu X, Calle J, Gebreselassie S, Monga M (2014) Can 24-hour urine stone risk profiles predict urinary stone composition? J Endourol 28(6):735鈥?38. doi:10.1089/end.2013.0769 href="http://dx.doi.org/10.1089/end.2013.0769" target="_blank" title="It opens in new window">CrossRef
  52. Friedlander JI, Moreira DM, Hartman C, Elsamra SE, Smith AD, Okeke Z (2014) Age-related changes in 24-hour urine composition must be considered in the medical management of nephrolithiasis. J Endourol 28(7):871鈥?76. doi:10.1089/end.2014.0002 href="http://dx.doi.org/10.1089/end.2014.0002" target="_blank" title="It opens in new window">CrossRef
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Urology and Andrology
  Nephrology
  Oncology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-8726

文摘

Introduction Urolithiasis is a complex medical entity and regroups several different types of stones, each caused by a multitude of dietary imbalances or metabolic anomalies. In order to better assess the stone-forming patient, urologists should be competent in performing a thorough metabolic work-up. Materials and methods We reviewed the litterature in order to provide an appropriate overview of the various components of the metabolic evaluation, including stone analysis, biochemistry tests, and urine collection. Conclusion Performing a metabolic evaluation allows precise intervention in order to treat and mainly prevent stone disease.